Mesozeaxanthin formulations for treatment of retinal disorders
1. A pharmaceutical composition comprising an effective dose of meso-zeaxanthin and a carrier or diluent.
Meso-zeaxanthin compositions for pharmaceutical use and use of meso-zeaxanthin to increase the deposition of macular pigment in the human eye, and for the therapeutic treatment or prophylaxis of diseases and disorders of the macula, in particular age-related macular degeneration (AMD).
- 1. A pharmaceutical composition comprising an effective dose of meso-zeaxanthin and a carrier or diluent.
11. A method of producing a pharmaceutical composition containing meso-zeaxanthin, said method comprising mixing meso-zeaxanthin with a pharmaceutically acceptable carrier or diluent.